41 records, the earliest from 3 Aug 2018. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
41 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Purpose | Notes |
|---|---|---|
| 23 Jul 2026 | Financial Results | To consider and approve the unaudited Standalone and Consolidated financial results for the quarter ended June 30, 2026 |
| 15 May 2026 | Financial Results | Solara Active Pharma Sciences Limited has informed the exchange that the meeting of the Board of Directors of the Company is scheduled to be held on May 15, 2026, inter alia, to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended on March 31, 2026 |
| 6 Feb 2026 | Financial Results | To consider and approve the Standalone and Consolidated financial results for the quarter ended December 31, 2025 |
| 5 Nov 2025 | Financial Results | Solara Active Pharma Sciences Limited has informed the Exchange about the Board Meeting to be held on November 05, 2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the quarter and half year ended September 30, 2025. |
| 25 Jul 2025 | Financial Results | To consider and approve unaudited standalone and consolidated Financial Results for the quarter ended June 30, 2025 |
| 15 May 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
| 2 Apr 2025 | Other business matters | Solara Active Pharma Sciences Ltd has informed exchange that the meeting of the Rights Issue Committee members of Board of Directors of the Company is scheduled on 02/04/2025 ,inter alia, to consider and approve the Notice of First Call to be sent to the eligible Shareholders. |
| 26 Mar 2025 | Other business matters | To consider and approve the proposal of making First Call on 1,19,98,755 partly paid-up Equity Shares, having a face value of Rs.10/- each (Rs.3.50/- paid-up) issued by the Company on rights basis. |
| 24 Jan 2025 | Financial Results | To consider and approve the unaudited financial results (Standalone and Consolidated) for the Quarter and Nine months period ended December 31, 2024 |
| 21 Oct 2024 | Financial Results | To consider and approve the Unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2024 |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
